Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
KALA BIO
AddedFeb 20, 2024
UpdatedJul 4, 2026
KALA BIO

KALA BIO

Public

Texas-based KALA BIO, Inc. is a clinical-stage biopharmaceutical company, innovating drug delivery for mucosal tissues globally.

HQ
Arlington, MA, US
Founded
2009
Overview
Compare
Employees
Website

KALA BIO, Inc., founded in Arlington, Texas, is a clinical-stage biopharmaceutical company dedicated to addressing rare and serious eye diseases. The company's core mission is to develop innovative therapies that leverage advanced science to penetrate mucosal tissues such as the eyes, lungs, gastrointestinal tracts, and female reproductive systems. KALA BIO's primary focus is on the research and development of mesenchymal stem cell secretome (MSC-S) therapies, aiming to provide regenerative healing effects for ocular surface and retinal diseases, ultimately preserving vision.

Notable figures affiliated with KALA BIO include leading scientists and researchers in the field of biopharmaceuticals. The company has attracted significant investment from prominent venture capital firms specializing in healthcare and biotechnology. Key achievements include the successful development of their proprietary MSC-S platform and the progression of several therapies into clinical trials. KALA BIO's impact is marked by its potential to revolutionize treatment for rare eye diseases, offering hope and improved quality of life for patients worldwide.

KALA BIO - Similar Companies

KaloBios Pharmaceuticals logo

KaloBios Pharmaceuticals

kalobios.com

Qlaris Bio logo

Qlaris Bio

qlaris.bio

Cell Care Therapeutics logo

Cell Care Therapeutics

cell-care.com

Beilai Bio logo

Beilai Bio

baylxinc.com

EyeCyte logo

EyeCyte

eyecyte.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

PMGC Holdings logo

PMGC Holdings

Kriya Therapeutics logo

Kriya Therapeutics

KaloCyte logo

KaloCyte

kalocyte.com

RainBio logo

RainBio

rainbio.us

Kallyope logo

Kallyope

kallyope.com

Tela Bio logo

Tela Bio

telabio.com

Kezar Life Sciences logo

Kezar Life Sciences

LaCell logo

LaCell

KALA BIO - Quick Facts

Who are KALA BIO's competitors?

Companies similar to KALA BIO include KaloBios Pharmaceuticals, Qlaris Bio, Cell Care Therapeutics and Beilai Bio.

When was KALA BIO founded?

KALA BIO was founded in 2009.

Where is KALA BIO's headquarters located?

KALA BIO's headquarters is located in Arlington, MA, US.

How many employees does KALA BIO have?

KALA BIO has 34 employees as of Feb 6, 2024.

KALA BIO - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Main Product
  • Biopharmaceuticals
Tags
  • Healthtech
Unique IDs
  • secCik: 0001479419
  • ticker: KALA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research